Expects strong sales in the region as demand for quality increases
Schott Pharmaceutical Systems, a German supplier of glass tubing and primary packaging for the pharmaceutical sector, is opening a new production plant in Russia this month and plans to strengthen its position in Japan.
The Russian facility, located in Zavolzhe, near Nizhny Novgorod, east of Moscow, will initially employ around 60 people and produce premium quality ampoules and vials. All products will be manufactured according to cGMP guidelines.
Dr Juergen Sackhoff, executive vice president of Schott Pharmaceutical Systems, speaking at Interpack, said: ‘I see strong sales there; we are the first strong international player to open a production facility in Russia.’
Schott has been selling ampoules, vials, cartridges and syringes to the Russian market since the beginning of the 1990s. So far, customers have been supplied from Schott’s plant in Hungary.
Mainz, Germany based Schott has also formed a joint venture in Japan with Naigai Glass Industry Co. The new company, Schott Naigai, is based in Osaka, where Naigai has been operating a production plant for many years.
Under the terms of the joint venture, Naigai will transfer its vial manufacturing activities over to the new company. Sackhoff said Schott had installed its highly advanced Automated Inspection System at the plant.
With new business operations also in China and Argentina, Schott now has more than 600 production lines in 14 countries worldwide, annually producing more than seven billion syringes, vials, ampoules, cartridges and special products.